What's the Skinny on SCOTUS' Skinny Label Decision?

The Supreme Court’s recent Hikma v. Amarin decision has renewed attention on induced infringement of method-of-use claims in Hatch-Waxman cases. This CLE will contextualize the decision and explore the extent to which it represents a mere refocusing of the law rather than a dramatic shift.

The discussion will offer takeaways for brand companies, generic companies, and counsel alike when it comes to litigation strategy, product communications, and risk assessment in navigating method-of-use patents in the post-Hikma landscape.

CLE: CA and NY pending